Fundraising FoxThe Blue Box Biomedical
3 known investors
Find your way into The Blue Box Biomedical
Sign up to see every warm intro you have to The Blue Box Biomedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the The Blue Box Biomedical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
The Blue Box is a diagnostic device that uses a urine reader with an electronic nose and AI analysis to detect breast cancer biomarkers in women aged 20-49 who lack reliable screening methods. The company has validated its technology through pilots with over 450 patients across 7 hospitals.
Founders & leadership
JG
Judit Giró BenetCo-Founder & CEOJudit Giró Benet is co-founder and CEO of The Blue Box Biomedical, which develops a diagnostic device that uses urine analysis and AI to detect breast cancer biomarkers in women aged 20-49.
Investors · 3
Fund FreportedVienna · $660K
How we know: press coverage · Not right? Tell us
Unconventional VenturesreportedCopenhagen
How we know: press coverage · Not right? Tell us
Frequently asked questions
- What does The Blue Box Biomedical do?
- The Blue Box is a diagnostic device that uses a urine reader with an electronic nose and AI analysis to detect breast cancer biomarkers in women aged 20-49 who lack reliable screening methods. The company has validated its technology through pilots with over 450 patients across 7 hospitals.
- Who founded The Blue Box Biomedical?
- The Blue Box Biomedical was founded by Judit Giró Benet, Lidia Navarro Farre.
- Who are The Blue Box Biomedical's investors?
- The Blue Box Biomedical's investors include WakeUp Capital, Fund F, Unconventional Ventures.